TrialDiabetes care2024

Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program.

Philip Zeitler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.